Last checked at 27 Apr 2023 15:55
27 April 2023
HeiQ Plc
("HeiQ" or "the Company")
Temporary Suspension
The Board of HeiQ Plc (LSE: HEIQ), a leading company in materials innovation and hygiene technologies, announces that the Company will not publish its audited financial results for the year ended 31 December 2022 by 30 April 2023 ("FY 2022 Accounts"), as required by the FCA's Disclosure Guidance and Transparency Rule 4.1.3.
The Company has been delayed in the preparation of its annual results principally as a result of the acquisition and implementation of new systems as well as changes to processes within the organisation. This has impacted the timing of the audit work, in this first year for the Company's new auditor, Deloitte.
The Company has therefore applied to the Financial Conduct Authority ("FCA") for the listing on the Official List of the FCA of its ordinary shares of 30p each to be temporarily suspended with effect from 7:30 a.m. on 2 May 2023. The suspension from trading will be lifted once the 2022 Accounts have been published. The Directors anticipate that the Company will be in a position to publish the audited report and accounts in the coming weeks. The Company will provide further market updates around the expected timing of the annual results once its financial reporting and the audit work is sufficiently progressed.
The information contained within this announcement is deemed to constitute inside information as stipulated under Article 7 of EU Regulation 596/2014 (which forms part of domestic UK law pursuant to the European Union (Withdrawal) Act 2018). Upon the publication of this announcement, this inside information is now considered to be in the public domain.
For further information, please contact:
HeiQ Plc Carlo Centonze (CEO) | +41 56 250 68 50 |
Cenkos Securities plc (Broker) Stephen Keys / Callum Davidson | +44 (0) 207 397 8900 |
SEC Newgate (Media Enquiries) Elisabeth Cowell / Molly Gretton | +44 (0) 20 3757 6882 heiq@secnewgate.co.uk |
About HeiQ
HeiQ is focused on improving the lives of billions of people world-wide by innovating the materials people use every day. HeiQ has strong IP which is at the forefront of global technology in the $10 billion antimicrobial fabrics market, $24 billion textile chemicals market, the $50 billion probiotics market and the $150 billion man-made fibers market. It has also moved into the medical device, healthcare and hygiene coatings markets, to help make hospitals and healthcare environments more hygienic. HeiQ aims to deliver growth for its shareholders through a combination of increased sales of its core products and by entering additional lucrative markets through disruptive innovations and M&A.
HeiQ has created some of the most effective, durable and high-performance technologies in the market today, which cool, warm, dry, repel, purify, and destroy viruses. Since 2005, HeiQ has developed over 200 technologies in partnership with 300 major brands and it has a significant R&D pipeline containing over 50 projects. The Company has won multiple awards and gained a strong reputation for the ESG & sustainable downstream effect of its innovations. HeiQ is the only company to have won the Swiss Technology award twice. It has also won the Swiss Environmental award with an innovation that saves energy and water consumption during the textile manufacturing process.
Led by an experienced leadership team, HeiQ researches new solutions for partners, delivers scaled up manufacturing from its sites across the world and helps partners market the product to end consumers - aiming for lab to consumer in months.